Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR Equipment Designed for Clinical Laboratories

By LabMedica International staff writers
Posted on 10 Dec 2012
A real-time polymerase chain reaction (PCR) instrument has been designed to meet the specific needs of clinical diagnostic laboratories. More...


The apparatus can perform numerous diagnostic functions, including pathogen detection, gene expression analysis, single nucleotide polymorphism (SNP) genotyping, copy number analysis, mutation detection, micro-ribonucleic acid (RNA) and other noncoding RNA analysis, and high-resolution melt analysis.

The QuantStudioDx Real-Time PCR Instrument (Applied Biosystems, Carlsbad, CA, USA) is a Conformité Européenne in vitro diagnostic device (CE-IVD) marked for use in Europe and represents a significant extension of their parent company Life Technologies’ product offerings in the diagnostics arena. The instrument’s touch screen, reagent and sample tracking, and Laboratory Information Management Systems (LIMS) interface are specifically designed for ease of use.

Flexibility is enabled through easily interchangeable thermal cycling blocks that accommodate 96- or 384-well plates and a proprietary quantitative real time PCR (qPCR) microfluidics card, which can perform 48 tests on eight samples concurrently without the need for liquid-handling robots. The card can also be used to design and implement custom tests. Life Technologies (Carlsbad, CA, USA) is currently developing diagnostic tests utilizing this format.

The instrument is being released with CE-marked Quidel Molecular Assay for Clostridium difficile for detection of hospital-acquired infections, which Life Technologies distributes. Additional Quidel Molecular infectious disease applications are currently under development and will be available in 2013, including an influenza A + B Assay, a human metapneuomvirus (hMPV) + respiratory syncytial virus (RSV) Assay, and a herpes simplex virus 1 and 2, and varicella zoster virus (chicken pox and shingles) assay.

Ronnie Andrews, BS, president of Medical Sciences at Life Technologies, said, “Molecular diagnostic tests based on real-time PCR have become indispensable to the clinical laboratory. Molecular testing is the fastest-growing segment of the diagnostics market, and the QuantStudio Dx instrument has unique features that will allow us to capture that market growth.”

Related Links:

Applied Biosystems
Life Technologies



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.